US20080029105A1 - Minimally-invasive devices and methods for treatment of congestive heart failure - Google Patents

Minimally-invasive devices and methods for treatment of congestive heart failure Download PDF

Info

Publication number
US20080029105A1
US20080029105A1 US11/729,165 US72916507A US2008029105A1 US 20080029105 A1 US20080029105 A1 US 20080029105A1 US 72916507 A US72916507 A US 72916507A US 2008029105 A1 US2008029105 A1 US 2008029105A1
Authority
US
United States
Prior art keywords
left ventricle
heart
patient
reducing
dimension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/729,165
Inventor
John Stevens
Lee Bolduc
Stephen Boyd
Brian Donlon
Hanson Gifford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/023,778 external-priority patent/US5452733A/en
Priority claimed from US08/163,241 external-priority patent/US5571215A/en
Priority claimed from US08/685,262 external-priority patent/US6125852A/en
Priority claimed from US09/950,917 external-priority patent/US20020029783A1/en
Application filed by Ethicon Inc filed Critical Ethicon Inc
Priority to US11/729,165 priority Critical patent/US20080029105A1/en
Publication of US20080029105A1 publication Critical patent/US20080029105A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B17/0218Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B17/0293Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors with ring member to support retractor elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06061Holders for needles or sutures, e.g. racks, stands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/122Clamps or clips, e.g. for the umbilical cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/50Supports for surgical instruments, e.g. articulated arms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/10Cooling bags, e.g. ice-bags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0467Instruments for cutting sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B17/2909Handles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00039Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
    • A61B2017/00044Sensing electrocardiography, i.e. ECG
    • A61B2017/00048Spectral analysis
    • A61B2017/00053Mapping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00632Occluding a cavity, i.e. closing a blind opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00902Material properties transparent or translucent
    • A61B2017/00907Material properties transparent or translucent for light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00946Material properties malleable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B2017/0237Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B2017/0237Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery
    • A61B2017/0243Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery for immobilizing local areas of the heart, e.g. while it beats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/047Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery having at least one proximally pointing needle located at the distal end of the instrument, e.g. for suturing trocar puncture wounds starting from inside the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0472Multiple-needled, e.g. double-needled, instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0474Knot pushers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0475Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery using sutures having a slip knot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B17/2909Handles
    • A61B2017/2912Handles transmission of forces to actuating rod or piston
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B2017/2926Details of heads or jaws
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B2017/2926Details of heads or jaws
    • A61B2017/2927Details of heads or jaws the angular position of the head being adjustable with respect to the shaft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B2017/2926Details of heads or jaws
    • A61B2017/2932Transmission of forces to jaw members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B2017/2926Details of heads or jaws
    • A61B2017/2932Transmission of forces to jaw members
    • A61B2017/2943Toothed members, e.g. rack and pinion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30Surgical pincettes without pivotal connections
    • A61B2017/306Surgical pincettes without pivotal connections holding by means of suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30Surgical pincettes without pivotal connections
    • A61B2017/306Surgical pincettes without pivotal connections holding by means of suction
    • A61B2017/308Surgical pincettes without pivotal connections holding by means of suction with suction cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3403Needle locating or guiding means
    • A61B2017/3405Needle locating or guiding means using mechanical guide means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B2017/348Means for supporting the trocar against the body or retaining the trocar inside the body
    • A61B2017/3492Means for supporting the trocar against the body or retaining the trocar inside the body against the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • A61B2018/00232Balloons having an irregular shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • A61B2018/0025Multiple balloons
    • A61B2018/00261Multiple balloons arranged in a line
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00273Anchoring means for temporary attachment of a device to tissue
    • A61B2018/00291Anchoring means for temporary attachment of a device to tissue using suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00363Epicardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00392Transmyocardial revascularisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00982Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/061Measuring instruments not otherwise provided for for measuring dimensions, e.g. length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/30Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
    • A61B2090/306Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001Body part
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/10Cooling bags, e.g. ice-bags
    • A61F2007/101Cooling bags, e.g. ice-bags for cooling organs in the body before or during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • A61M2025/028Holding devices, e.g. on the body having a mainly rigid support structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/027Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body having a particular valve, seal or septum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0279Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for introducing medical instruments into the body, e.g. endoscope, surgical tools
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/047Liquids non-physiological cardioplegic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3344Measuring or controlling pressure at the body treatment site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3355Controlling downstream pump pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • A61M2205/366General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters

Definitions

  • CHF congestive heart failure
  • the heart has become so enlarged as a result of viral infection, myocardial infarction or other disease that it is unable to pump at a sufficient rate to maintain adequate circulation of blood throughout the body.
  • blood backs up into the lungs, causing shortness of breath and other symptoms, and, if left untreated, the disease can lead to death.
  • the CHF may be treated effectively with medication.
  • the disease progresses to a point at which the patient requires a heart transplant.
  • the Batista Operation can extend the life of a patient who would otherwise die without a transplant, it is a highly invasive and traumatic procedure.
  • the chest In order to expose the heart, the chest must be opened widely by sawing the sternum in half and spreading apart the rib cage, known as a median sternotomy, producing a great deal of pain, risk of infection, and long recovery time.
  • the trauma produced by the operation could contribute significantly to the mortality and morbidity associated with the procedure.
  • the Batista Operation has typically been performed while the heart is beating, causing a great deal of blood loss through the ventricular incision, and risking the introduction of air into the bloodstream, potentially causing stroke or other neurological problems.
  • the heart could be stopped and isolated from the rest of the circulatory system during the procedure by placing an external aortic cross-clamp on the ascending aorta and using conventional cardioplegia and cardiopulmonary bypass.
  • cross-clamps may produce the added risk of releasing calcific particles from the inner walls of the aorta, which may embolize in the bloodstream and produce neurological events such as stroke. Moreover, the risk remains that air will become trapped in the ventricle after it has been closed, allowing the air to migrate to the brain as soon as the cross-clamp is removed. Conventional cross-clamps also require a large opening in the chest in order to gain access to the aorta, hindering any effort to reduce the trauma associated with the procedure.
  • the devices and techniques should facilitate the identification of an appropriate section of the left ventricular wall, excision or other reshaping of the section, and, if the section is removed, closure of the left ventricle, without requiring a gross thoracotomy or median sternotomy. If the left ventricle is opened, the devices and techniques should allow the patient to be placed on cardiopulmonary bypass and the heart to be arrested and isolated from the circulatory system without the need for an external aortic cross-clamp. Further, the devices and techniques should minimize that risk that either air and other emboli will be produced by the procedure.
  • the invention provides devices and methods for treating CHF, as well as other diseases resulting in an enlarged heart, that not only significantly reduce the pain and trauma to the patient, but that may reduce the risk of infection and the risk of neurological events associated with the Batista Operation.
  • the invention facilitates the reduction of left ventricular volume by removing a section of the heart wall or otherwise reshaping the ventricle without requiring a median sternotomy or gross thoracotomy.
  • the invention further allows the procedure to be performed on cardiopulmonary bypass with the heart isolated and arrested, yet without the gross thoracic incision required by, or the risk of embolism produced by, conventional aortic cross-clamps.
  • the invention may significantly reduce the risk that air will be introduced into the bloodstream and embolized to the brain during or after the procedure.
  • the invention provides a method of reshaping a patient's heart, comprising the steps of:
  • the ascending aorta is preferably occluded by means of an occlusion balloon attached to the distal end of an elongated catheter positioned transluminally in the aorta from a femoral, subclavian, or other appropriate peripheral artery.
  • Cardioplegic fluid may then be delivered upstream of the occlusion balloon through a lumen in that catheter, and/or delivered in a retrograde manner through a separate catheter placed transluminally into the coronary sinus from a peripheral vein.
  • circulation of oxygenated blood is maintained preferably by peripheral extraporeal cardiopulmonary bypass (CPB), wherein blood is removed from a peripheral vein via a venous drainage catheter, filtered, oxygenated, and returned to a peripheral artery through an arterial return catheter.
  • CPB peripheral extraporeal cardiopulmonary bypass
  • the need for the median sternotomy through which such a cross-clamp is placed is also eliminated.
  • the left ventricle may then be reshaped and volumetrically reduced using thoracoscopic instruments positioned through small incisions, punctures or ports located in the intercostal spaces between the ribs.
  • the invention further provides a method of reshaping a patient's heart comprising the steps of:
  • a section of the left ventricular wall is excised with a cutting device, then the left ventricle is closed using sutures, staples or other means for wound approximation and closure, each applied using thoracoscopic instruments with the user's hands maintained generally outside of the chest.
  • a section of the left ventricular wall is gathered together or pursed outwardly or inwardly to produce one or more folds or pleats in the wall. These folds or pleats are then thoracoscopically sutured, stapled or otherwise fastened permanently in place to reduce the transverse dimension of the left ventricle.
  • the left ventricular wall may be approached in several different ways.
  • one or more small incisions, punctures, trocar sleeves, tissue retractors or other type of ports are placed in intercostal spaces in the left anterior and/or lateral side of the chest, preferably between the third and seventh intercostal spaces.
  • This permits direct access to the outer wall of the left ventricle on the lateral and posterior sides of the heart, usually with minor retraction of the apex of the heart anteriorly using thoracoscopic graspers or other retraction instruments.
  • the heart may then be viewed directly through an intercostal port, or by means of a thoracoscope positioned through an intercostal port to permit either direct or video-based viewing of the heart.
  • ports are placed are in the right lateral side of the chest between the third and seventh intercostal spaces.
  • an incision is then made in the left atrium on the posterior side of the heart, and the incision retracted to expose the mitral valve.
  • the mitral valve apparatus is excised from the heart, providing access into the interior of the left ventricle through the mitral valve annulus.
  • a thoracoscopic scissors or knife is then used to excise a portion of the left ventricular wall from the inside of the chamber, either under direct vision from a port in the right side of the chest, or under video-based vision using a thoracoscope positioned through a port into the heart.
  • the procedure may be viewed from outside of the heart as well by placing a thoracoscope through a port in the left lateral or anterior side of the chest.
  • the left ventricular wall may then be closed using sutures, staples, or other means applied with an instrument introduced through the mitral annulus from the right chest, or through a port placed in the left lateral or anterior side of the chest as described above.
  • a restrictive girdle or band is placed around the outside of the heart to restrict the left ventricle to the desired diameter or volume.
  • the band or girdle is preferably elastic so as to expand and contract with the heart as it pumps.
  • the girdle or band is applied to the heart using specialized thoracoscopic instruments placed through intercostal spaces in the rib cage while generally maintaining the user's hands outside the chest, thereby eliminating the need for a gross thoracotomy.
  • the methods of the invention may reduce the risk that air will pass through the ventricular incision and into the bloodstream.
  • the invention also allows the chest to be flooded with carbon dioxide or other suitable gas during the procedure to maintain the chest cavity free of air.
  • a tube may be placed through one of the intercostal ports and gas delivered through the tube into the chest at a pressure suitable to ensure that air cannot enter the chest cavity.
  • trocar sleeves or tubular ports may be used which have internal seals like those used for gaseous insufflation in laparoscopic procedures, thereby preventing the unwanted introduction of air into the chest.
  • the left ventricle and aorta may be flushed with saline and then vented through a lumen in the aortic occlusion catheter while maintaining aortic occlusion, thereby removing any trapped air that may be present.
  • FIG. 1 is an anterior view of a patient's torso schematically illustrating the use of an endovascular cardiopulmonary bypass system according to the invention.
  • FIG. 2 is an anterior view of a patient's chest illustrating the placement of intercostal ports and thoracoscopic instruments according to the invention.
  • FIGS. 3-5 are posterior views of a patient's heart illustrating the removal of a section of the left ventricle and closure of the left ventricular wall according to the invention.
  • FIG. 6A is a transverse cross-section of a patient's chest illustrating an alternative approach to the left ventricle according to the invention.
  • FIG. 6B is a transverse cross-section of a patient's chest illustrating an alternative method of ventricular volume reduction according to the invention.
  • FIGS. 6C-6D are close-up cross-sections of the ventricular wall illustrating additional steps in the method of FIG. 6B .
  • FIGS. 7A-7B are transverse cross-sections of a patient's heart before and after treatment, respectively, illustrating the bifurcation of the left ventricle according to the invention.
  • FIG. 7C is a posterior view of a patient's heart illustrating the exterior shape of the left ventricle after bifurcation as in FIG. 7B .
  • FIG. 8A is a side view of a tissue gathering device according to the invention.
  • FIG. 8B is a top view of the distal end of the tissue gathering device of FIG. 8A .
  • FIG. 9A is a cross-section of a portion of the left ventricle illustrating the use of the tissue gathering device of FIG. 8A according to the method of the invention.
  • FIG. 9B is a posterior view of a patient's heart illustrating the heart after treatment using the tissue gathering device of FIG. 8A .
  • FIG. 10 is a posterior view of a patient's heart illustrating the use of a heart measurement device according to the invention.
  • FIG. 11 is a transverse cross-section of a patient's thorax illustrating the use of a left ventricular measurement device according to the invention.
  • an endovascular cardiopulmonary bypass (CPB) system useful in the method of the invention is illustrated as it is used in a patient. Additional aspects of such endovascular CPB systems suitable for use in the methods of the invention are described in the following patent applications, which are incorporated herein by reference: Ser. No. 08/282,192, filed Jul. 28, 1994, now U.S. Pat. No. 5,584,803, Ser. No. 08/612,341, filed Mar. 7, 1996, and Ser. No. 08/486,216, filed Jun. 7, 1995, now U.S. Pat. No. 5,766,151.
  • the system includes a venous drainage cannula 20 placed into a femoral vein FV (or other suitable peripheral vein) and preferably having sufficient length to extend into the inferior vena cava IVC, the right atrium RA or the superior vena cava SVC.
  • Venous drainage cannula 20 is connected to an extracorporeal CPB system 22 , which filters and oxygenates the blood withdrawn from the patient.
  • the system further includes an arterial return cannula 24 placed into a femoral artery FA (or other peripheral artery such as the subclavian) through which CPB system 22 pumps oxygenated blood into the arterial system.
  • Arterial return cannula 24 , venous drainage cannula 20 and CPB system 22 are configured to provide full cardiopulmonary bypass with the patient's heart arrested.
  • the endovascular CPB system further includes an aortic occlusion catheter 26 that is positioned into femoral artery FA through a port 28 at the proximal end of arterial return cannula 24 .
  • Port 28 has a hemostatic seal (not shown) to prevent blood loss when occlusion catheter 26 is positioned through the port.
  • Occlusion catheter 26 has an occlusion balloon 30 at its distal end and a length sufficient to allow occlusion balloon 30 to be positioned in the ascending aorta AA, usually at least about 80 cm.
  • Occlusion catheter 26 preferably has at least three lumens, including an inflation lumen in communication with the interior of balloon 30 for delivery of an inflation fluid from a syringe 32 or other inflation device.
  • a pressure lumen is also provided which communicates with a pressure port in the catheter distal to balloon 30 , allowing pressure to be monitored by means of a pressure measuring device 34 .
  • Occlusion catheter 26 further includes a main lumen in communication with an additional port distal to balloon 30 to allow delivery of cardioplegic fluid from a cardioplegic fluid source 36 and to facilitate venting the aortic root by means of a suction pump 38 .
  • a two-way valve 40 permits selecting between cardioplegic fluid delivery or aortic root venting via the main lumen.
  • An optional component of the endovascular CPB system is a coronary sinus catheter 42 positioned transluminally into the coronary sinus CS via the internal jugular vein JV in the neck, the superior vena cava SVC, and right atrium RA.
  • Coronary sinus catheter 42 permits retrograde delivery of cardioplegic fluid in conjunction with or instead of antegrade delivery through aortic occlusion catheter 26 .
  • the distal end of catheter 42 includes a balloon 44 configured to occlude the coronary sinus CS.
  • Sinus catheter 42 has at least two lumens, including an inflation lumen in communication with balloon 44 , and a delivery lumen in communication with a port distal to balloon 44 for delivering cardioplegic fluid into coronary sinus CS.
  • a third lumen may optionally be provided for pressure measurement through a port distal to balloon 44 .
  • an endovascular venting catheter may be introduced into a vein in the neck and advanced through the superior vena cava, the right atrium, the right ventricle and into the pulmonary artery for venting blood from the heart, as described in co-pending application Ser. No. 08/415,238, filed Mar. 30, 1995, which is incorporated herein by reference.
  • aortic occlusion catheter 26 is inserted through arterial return cannula 24 and slidably advanced toward the heart until occlusion balloon 30 is in the ascending aorta AA. Balloon 30 is then inflated to fully occlude the aortic lumen between the coronary ostia (not shown) and the brachiocephalic artery BA.
  • Cardioplegic fluid usually consisting of a cold potassium chloride solution mixed with oxygenated blood, is then delivered into the ascending aorta through the main lumen of occlusion catheter 26 , from which it flows into coronary arteries and perfuses the myocardium, stopping cardiac contractions.
  • coronary sinus catheter 42 balloon 44 may be inflated and cardioplegic fluid delivered into the coronary sinus CS, from which it flows through the coronary veins to perfuse the myocardium.
  • valve 40 is switched to allow the aortic root to be vented of fluid via occlusion catheter 26 .
  • Aortic root pressure may be continuously monitored using pressure measurement device 34 .
  • a number of surgical ports 50 are placed in intercostal spaces IS between the ribs R. These ports may be simple plastic tubes having flanges at their proximal ends to prevent passage entirely into the chest and having sufficient rigidity to retract intercostal tissue so as to form an opening. Trocar sleeves or small bladed rib retractors may also be used.
  • a soft tissue retractor that may be particularly useful in the method of the invention is described in application Ser. No. 08/610,619, filed Mar. 4, 1996, now U.S. Pat. No.
  • Ports 50 may be positioned in any of several regions of the chest, depending upon the desired approach to heart.
  • ports 50 are preferably placed in the fourth, fifth, sixth or seventh intercostal spaces on the left anterior and/or left lateral side of the patient's chest.
  • ports 50 are placed in the right lateral side of the chest in the second, third, fourth, fifth, or sixth intercostal spaces.
  • the exact location of ports 50 will depend upon the location of the surgical site on the heart, individual patient anatomy, and surgeon preference.
  • One or both of the patient's lungs may have to be partially or fully collapsed during the procedure in order to gain access to the heart.
  • the pericardium PC is incised, as illustrated in FIG. 2 , using thoracoscopic scissors 52 , an electrocautery probe or other appropriate cutting devices, along with graspers 54 or other retraction devices, inserted through ports 50 .
  • Suitable instruments are described in U.S. Pat. No. 5,501,698, which is incorporated herein by reference.
  • a thoracoscope 56 is inserted through one of ports 50 to facilitate visualization.
  • Thoracoscope 56 includes a camera 58 which produces a video image of the interior of the chest that can be viewed on a video monitor (not shown).
  • Various conventional thoracoscopes may be used, including the articulating Welch-Allyn DistalView 360 (Welch-Allyn, Skaneateles Falls, N.Y.), or a 30 ⁇ angled endoscope available from Olympus Optical (Lake Success, N.Y.).
  • the surgeon may also look directly into the chest through ports 50 , assisted by illumination of the chest by means of a light probe inserted through a port.
  • the pericardium is opened or removed from around the left ventricle to expose the surgical site.
  • a portion of an outer wall of the left ventricle is removed and the wall then reclosed so as to reduce the traverse dimension and volume of the ventricular chamber.
  • a cutting device such as a knife 60 along with thoracoscopic graspers 62 are inserted though ports 50 and used to excise the desired portion of the ventricular wall.
  • some retraction of the heart may be required, by for example, grasping the apex of the heart with graspers 62 and moving the apex anteriorly so as to expose the posterior aspect of the left ventricle.
  • a stab wound is made near the apex AP of the heart and an incision extended superiorly toward the left atrium in an arc bowing outwardly toward the left side of the heart.
  • a second incision is made from the apex in an opposing arc bowing outwardly toward the right side of the heart and intersecting the first incision near the coronary sinus CS, allowing a football-shaped section of myocardial tissue to be removed. This leaves an opening OP in the left ventricular wall as illustrated in FIG. 4 .
  • Opening OP is then sutured closed using thoracoscopic needle drivers 64 to drive curved needle 66 and suture 68 through ventricular wall VW and using graspers 62 to assist in approximating the opposing edges of the opening.
  • thoracoscopic needle drivers 64 to drive curved needle 66 and suture 68 through ventricular wall VW and using graspers 62 to assist in approximating the opposing edges of the opening.
  • a relatively coarse running stitch is placed in the wall to draw opening OP closed, and a finer running stitch is then applied to ensure the wound is hemostatically sealed.
  • the exact location and amount of tissue removed from the left ventricular wall will vary according to the type and severity of disease and other factors.
  • the effectiveness of the heart in pumping blood will generally be increased by reducing the transverse dimension of the left ventricle so as to reduce the overall volume of the chamber. This allows less blood to flow into the left ventricle before each contraction, thereby reducing the outward force of the blood against the ventricle when it contracts.
  • a sufficiently large section of the ventricular wall will be removed to reduce the ventricle to having a transverse dimension (generally perpendicular to the interventricular septum) on the order of 4 to 7 cm.
  • opening OP in the left ventricular wall will be formed between the anterior and posterior papillary muscles, avoiding unnecessary damage to the mitral valve apparatus.
  • the mitral valve apparatus is damaged or removed during the procedure, requiring replacement or repair of the valve following removal of the ventricular wall section. This may be accomplished by introducing an annuloplasty ring or prosthetic valve into the heart through ports 50 and opening OP and securing the prosthesis at the mitral valve position using thoracoscopic instruments introduced through ports 50 .
  • the mitral valve may be replaced via ports in the right lateral side of the chest by entering the left atrium, using the techniques described in co-pending application Ser. No. 08/465,383, filed Jun. 5, 1995, now U.S. Pat. No. 5,682,906, which is hereby incorporated herein by reference.
  • saline may be delivered through the main lumen of the occlusion catheter into the aortic root, or a small catheter may be advanced through the occlusion catheter and into the left atrium through the aortic valve to deliver saline into the left ventricle.
  • the heart may be compressed using thoracoscopic probes to urge air out of the left ventricle.
  • the saline is then vented through occlusion catheter 26 to remove air and other emboli.
  • occlusion balloon 30 on aortic occlusion catheter 26 is deflated to allow blood from arterial return cannula 24 to reach the coronary ostia. If cardiac contractions do not resume spontaneously, an electric shock may be delivered to the heart using thoracoscopic or external defibrillation paddles. When the heart is in sinus rhythm, the patient is weaned from cardiopulmonary bypass, vascular punctures are closed, and the patient recovered from general anesthesia.
  • ports 50 may be provided with gaseous seals like those used in laparoscopic trocar sleeves to maintain an air-free environment within the chest.
  • a gas such as carbon dioxide that is not likely to embolize in the blood stream may be delivered into the chest at a sufficient rate and pressure to prevent air from entering.
  • Other techniques for preventing air embolism are described in co-pending application Ser. No. 08/585,871, filed Jan. 12, 1996, now U.S. Pat. No. 5,849,005 which is incorporated herein by reference.
  • FIG. 6A-6D are transverse cross-sections of a patient's thorax and heart illustrating additional embodiments of the method of the invention.
  • a right chest approach is used similar to that described in co-pending application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, which has been incorporated herein by reference. That application describes techniques for opening the pericardium, forming and retracting an atrial incision, removing the mitral valve, and implanting a valve prosthesis which may be utilized in the method of the present invention.
  • ports 50 A are placed in the second, third, fourth, fifth, or sixth intercostal spaces in the right lateral side of the chest.
  • additional ports 50 B may be placed in the left lateral or left anterior sides of the chest to approach the left ventricle on the posterior side of the heart, as described above with reference to FIGS. 1-2 .
  • An opening is first formed in the pericardium using thoracoscopic instruments inserted through right chest ports 50 A and/or left chest ports 50 B so as to expose the left atrium LA and the left ventricle LV.
  • a thoracoscope 70 may be inserted through one of ports 50 A to view the interior of the chest, or the surgeon may view the chest cavity directly by looking through ports 50 A.
  • one or more of ports 50 A may be configured to provide a wider opening into the chest to allow greater maneuverability of instruments and to facilitate direct vision into the chest, such as the oval-shaped port described in application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, or the soft tissue retractor described in application Ser. No. 08/610,619, now U.S. Pat. No. 5,810,721, referenced above.
  • these will not require cutting or removing the ribs, and will minimize any retraction of the ribs, although in some cases it may be desirable to retract the ribs slightly or remove a small portion of a rib to provide greater access into the chest.
  • ports 50 A will generally not be large enough to allow the surgeon's hands to be placed into the chest, although it may be possible to place one or more individual fingers into the chest.
  • the right lung is collapsed, the pericardium is opened and the patient is on CPB with the heart arrested as described above.
  • An incision is made in the left atrium on the right lateral/posterior aspect of the heart using thoracoscopic scissors or knife inserted through a port 50 A.
  • the atrial incision is then retracted anteriorly using a thoracoscopic retractor 72 .
  • Suitable retractors are described in co-pending application Ser. No. 08/577,547, filed Dec. 22, 1995 which is hereby incorporated herein by reference. With the atrial incision retracted in this manner, the mitral valve is exposed at a direct line of sight from a port 50 A in the fourth, fifth, or sixth intercostal space in the right chest.
  • the mitral valve leaflets may then be removed using thoracoscopic scissors so that the left ventricle LV is visible through the mitral valve annulus VA.
  • the valve leaflets and chordae tendonae may alternatively be left intact, and a thoracoscope introduced through the valve into left ventricle LV to provide visualization within the chamber.
  • a section of the left ventricular wall VW is then removed using elongated thoracoscopic scissors 74 or other suitable cutting device introduced through a port 50 A and valve annulus VA.
  • Scissors 74 are used to excise a football-shaped section of ventricular wall tissue, preferably between the anterior and posterior papillary muscles.
  • An additional thoracoscope 76 may be introduced through left lateral chest ports 50 B with the left lung collapsed to visualize the outer wall of the left ventricle to ensure the desired section is removed without cutting into adjacent tissues.
  • Ventricular wall VW may be sutured from within the chamber with thoracoscopic needle drivers introduced through right chest ports 50 A and mitral valve annulus VA, or sutured from outside the heart using needle drivers inserted through left chest ports 50 B as described above in connection with FIG. 5 .
  • excellent access is provided through right chest ports 50 A to implant either a replacement valve or an annuloplasty ring, or perform any necessary surgical repair of the valve, in the manner described in co-pending application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, already incorporated herein by reference.
  • the left atrium is then closed. Ports 50 A, 50 B are removed and thoracic incisions are closed.
  • the heart is restarted and the patient is weaned from cardiopulmonary bypass as described above.
  • a section of the inner wall of the heart is removed while leaving a thin layer of the outer wall intact.
  • a thoracoscopic tissue-removing instrument 61 such as an end-biting biopsy or rongeur type instrument, may be utilized which has a pair of pivotable jaws 63 with tissue-cutting cup-shaped tips 65 that interact in a shearing relationship to bite off a portion of tissue, as shown in FIG. 6C .
  • a variety of other conventional endoscopic tissue removal instruments may also be used. In this way, a very thin section of the ventricular wall is created in the area which would otherwise be removed according to the alternative methods described above.
  • Ventricular wall VW is then drawn together and sutured so that the thin section of the wall is pursed outward, as shown in FIG. 6D .
  • a thoracoscopic needle driver 67 may be inserted through a right chest port 50 A and through the mitral valve to apply a suture 69 , or a needle driver may be inserted through a left lateral or anterior port 50 B to apply sutures from the exterior of the heart.
  • FIGS. 7A-7C illustrate a further embodiment of the method of the invention.
  • the ventricle is reshaped by attaching a central longitudinal section of the ventricular wall VW to the interventricular septum IS. This is most readily accomplished by inserting a thoracoscopic tissue attachment device through left chest ports 50 B ( FIG. 2 ), exerting inward pressure against the left ventricular wall VW until it abuts septum IS, and securing wall VW to septum IS.
  • the tissue attachment device comprises, in an exemplary embodiment, an insertion device 71 for applying a T-shaped fastener like that described in reissued U.S. Pat. No. Re34,021, incorporated herein by reference.
  • Insertion device 71 has a tubular shaft 73 with a sharpened distal end 75 used to penetrate ventricular wall VW and interventricular septum IS.
  • a suture 77 is attached to a central portion of a fastener 80 (not shown in FIG. 7A ) which is removably positioned in tubular shaft 73 during insertion.
  • a second suture 79 is also attached to an end of fastener 80 for removal purposes, as described in the aforementioned reissue patent.
  • an obturator (not shown) is positioned through tubular shaft 73 so as to deploy fastener 80 into the right ventricle RV.
  • Insertion device 71 is then removed from the heart, leaving sutures 77 , 79 extending through the septum IS and ventricular wall VW.
  • a retainer 81 slidably mounted on sutures 77 , 79 , is then advanced against ventricular wall VW to urge the ventricular wall against septum IS, as shown in FIG. 7B .
  • a series of fasteners 80 are applied in this way along a generally vertical line extending from the apex of the heart toward the superior aspect of the heart so as to bifurcate the ventricle into two separate chambers communicating with each other and with the aortic valve AV and mitral valve MV at the superior end of the chambers.
  • Each of the smaller chambers thus created has a smaller transverse dimension and volume than the left ventricle, and the contraction of each chamber is therefore opposed by a smaller outward force from blood present in the chamber than that to which the single larger ventricle is subject.
  • tissue attachment techniques may be used instead of the T-shaped fastener illustrated, including suturing by means of a large curved needle and thoracoscopic needle drivers, or skin or fascia type staplers.
  • a particular advantage of this technique is that it does not require the left ventricle to be opened and exposed to air, thereby eliminating the risk of air embolism resulting from the procedure. Additionally, the technique avoids any loss of blood from the ventricle, allowing it to be performed on the beating heart, without occluding the aorta, arresting the heart, or placing the patient on CPB.
  • Tissue gathering device 84 comprises an elongated tubular shaft 86 and an inner rod 88 extending slidably through shaft 86 .
  • a tissue engaging member 90 is attached to the distal end of rod 88 .
  • Tissue engaging member 90 comprises a pair of jaws 92 biased away from each other and connected at their proximal ends to rod 88 .
  • jaws 92 are engaged by the inner wall of shaft 86 such that sliding the shaft distally relative to rod 88 urges jaws 92 toward one another.
  • a plurality of sharp points or teeth 96 extend inwardly from a distal portion of jaws 92 and are configured to penetrate the ventricular wall, as described below.
  • Jaws 92 may be as narrow as the diameter of shaft 86 or even narrower, if desired, with only one or two opposing teeth 96 , but are preferably somewhat wider as illustrated, e.g. 1-5 cm in width (transverse to shaft 86 ), with three or more teeth 96 on each jaw, to facilitate gathering a wide section of tissue between them.
  • the distal transverse portion 97 of jaws 92 on which teeth 96 are disposed is preferably arcuate in shape to facilitate grasping a curved section of tissue between the jaws.
  • a handle 98 is attached to the proximal end of shaft 86 and includes a stationary handle member 100 having finger loops 101 and a movable handle member 102 pivotably attached to stationary handle member 100 and having thumb loop 103 .
  • the proximal end of rod 88 is attached to movable handle member 102 such that pivoting the movable handle member toward the stationary handle member pulls rod 88 proximally relative to shaft 86 , thereby closing jaws 92 .
  • a locking mechanism 104 facilitates maintaining the jaws in the closed position without maintaining pressure on handle 100 .
  • tissue gathering device 84 is introduced through a port 50 B ( FIG. 2 ) in the left lateral or anterior side of the chest selected to allow access to the left ventricle on the posterior side of the heart near the apex.
  • the heart may be retracted as necessary to facilitate access and visualization of the left ventricle either directly or by means of a thoracoscope.
  • Jaws 92 are positioned in the open position against the ventricular wall VW and closed so as to gather a section of ventricular wall tissue between the jaws, as illustrated in FIG. 9A .
  • this will be an arcuate section of tissue extending from a point near the apex superiorly along the left ventricle on the posterior side of the heart. Points 96 penetrate the outer surface of the ventricular wall to facilitate grasping the wall tissue and pursing it outwardly between the jaws. Locking mechanism 104 on handle 100 may then be engaged so as to lock jaws 92 in position, thereby maintaining the gathered section of ventricular wall tissue between jaws 92 .
  • the opposing halves of the folded section of wall tissue are then attached to one another near the base of the fold, using a large arcuate needle 108 attached to a suture 110 , driven by a thoracoscopic needle driver 112 inserted through a port 50 .
  • a running stitch may be applied, or a series of individual suture loops.
  • a thoracoscopic stapler, T-fastener applier, or other suitable tissue fastening device may be used.
  • FIG. 9B A large section FS of left ventricle LV has been folded outwardly and isolated from the remainder of the ventricle thereby reducing the transverse dimension and volume of the ventricle.
  • the outer portion of the folded section FS may be cut off and removed using a thoracoscopic scissors or knife.
  • the left ventricle is not opened during the procedure, eliminating the risk of air embolism, and avoiding blood loss, thus allowing the procedure to be performed on a beating heart without cardiac arrest and CPB.
  • FIGS. 10 and 11 illustrate two alternative embodiments for measuring left ventricular size.
  • a thoracoscopic heart measurement device 120 comprises a shaft 122 configured for insertion through a thoracic port between the ribs, and a flexible band 124 extending from the distal end of the shaft to form a loop.
  • Band 124 may be made of a flexible polymer or metal, and extends slidably through an inner lumen in shaft 122 so that the size of the loop may be contracted or expanded by extending or retracting band 124 from the distal end of the shaft.
  • the loop may be placed around the exterior of the heart H and cinched against the outer wall of the heart.
  • Measurement device 120 is then removed from the chest while maintaining the size of the loop, which may then be measured outside the chest to determine the circumference or diameter of the heart.
  • FIG. 11 An alternative embodiment of a ventricular measurement device 130 is illustrated in FIG. 11 .
  • Ventricular measurement device 130 includes a shaft 132 positionable through a right chest port 50 A, through a left atrial incision, through the mitral valve, and into the left ventricle LV.
  • Shaft 132 therefore has a length of at least about 20 cm, and usually about 25-40 cm.
  • An elastomeric balloon 134 is attached to the distal end of shaft 132 and has an interior in communication with an inflation lumen extending through shaft 132 .
  • An inflation device such as a syringe 136 is attached to the proximal end of shaft 132 in communication with the inflation lumen to facilitate delivery of an inflation fluid into balloon 134 .
  • Balloon 134 is of a size large enough to completely occupy the left ventricle, preferably being inflatable to a diameter of 4-12 cm. In this way, measurement device 130 may be introduced into the left ventricle via the left atrium and mitral valve and balloon 134 expanded until it engages the inner ventricular wall. By observing the volume of inflation fluid required to expand the balloon to this size, the approximate volume of the left ventricle may be assessed.
  • a penetration may be made in the wall of the left ventricle via a port in the left lateral or anterior side of the chest, and balloon 134 inserted directly through the penetration to measure left ventricular volume.
  • a purse string suture may be placed in the heart wall around the penetration to maintain hemostasis around shaft 132 .

Abstract

A method of treatment of congestive heart failure comprises the steps of introducing an aortic occlusion catheter through a patient's peripheral artery, the aortic occlusion catheter having an occluding member movable from a collapsed position to an expanded position; positioning the occluding member in the patient's ascending aorta; moving the occluding member from the collapsed shape to the expanded shape after the positioning step; introducing cardioplegic fluid into the patient's coronary blood vessels to arrest the patient's heart; maintaining circulation of oxygenated blood through the patient's arterial system; and reshaping an outer wall of the patient's heart while the heart is arrested so as to reduce the transverse dimension of the left ventricle. The ascending aorta may be occluded and cardioplegic fluid delivered by means of an occlusion balloon attached to the distal end of an elongated catheter positioned transluminally in the aorta from a femoral, subclavian, or other appropriate peripheral artery.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • This application is a Continuation of co-pending U.S. patent application Ser. No. 08/685,262, filed Jul. 23, 1996, which is a Continuation-In-Part of application Ser. No. 08/485,600, filed Jun. 7, 1995, which is a Continuation-In-Part of application Ser. No. 08/281,962, filed Jul. 28, 1994, which is a Continuation-In-Part of application Ser. No. 08/163,241, filed Dec. 6, 1993, now U.S. Pat. No. 5,571,2215, which is a Continuation-In-Part of application Ser. No. 08/023,778, filed Feb. 22, 1993, now issued as U.S. Pat. No. 5,452,733, the complete disclosures of which are hereby incorporated herein by reference for all purposes.
  • BACKGROUND OF THE INVENTION
  • In congestive heart failure or CHF, the heart has become so enlarged as a result of viral infection, myocardial infarction or other disease that it is unable to pump at a sufficient rate to maintain adequate circulation of blood throughout the body. As a result, blood backs up into the lungs, causing shortness of breath and other symptoms, and, if left untreated, the disease can lead to death.
  • For some patients, the CHF may be treated effectively with medication. However, in many cases, the disease progresses to a point at which the patient requires a heart transplant. Unfortunately, due to a donor shortage, of the 40,000 patients who may require a transplant each year, only 2500 actually get one, with up to 15-20% of patients dying while on the waiting list for a donor heart.
  • In response to the need for alternatives to transplant for treating CHF, a surgical procedure has been tried in recent years known as the “Batista Operation” after its developer, Dr. Randas J. V. Batista. In this procedure, a large section of the left ventricular wall is excised from the heart and the wall then sewn back together, thereby reducing the transverse dimension and volume of the left ventricle, the primary pumping chamber of the heart. The reduced volume of the ventricle permits less blood to be present in the chamber during each of its contractions, thus reducing the forces acting against the heart muscle as it contracts and allowing the heart to pump more effectively.
  • Although the Batista Operation can extend the life of a patient who would otherwise die without a transplant, it is a highly invasive and traumatic procedure. In order to expose the heart, the chest must be opened widely by sawing the sternum in half and spreading apart the rib cage, known as a median sternotomy, producing a great deal of pain, risk of infection, and long recovery time. For elderly or extremely ill patients, the trauma produced by the operation could contribute significantly to the mortality and morbidity associated with the procedure.
  • Moreover, the Batista Operation has typically been performed while the heart is beating, causing a great deal of blood loss through the ventricular incision, and risking the introduction of air into the bloodstream, potentially causing stroke or other neurological problems. To reduce blood loss and the risk of air embolism, the heart could be stopped and isolated from the rest of the circulatory system during the procedure by placing an external aortic cross-clamp on the ascending aorta and using conventional cardioplegia and cardiopulmonary bypass. However, because such cross-clamps crush the walls of the aorta together in order to occlude the vessel, cross-clamps may produce the added risk of releasing calcific particles from the inner walls of the aorta, which may embolize in the bloodstream and produce neurological events such as stroke. Moreover, the risk remains that air will become trapped in the ventricle after it has been closed, allowing the air to migrate to the brain as soon as the cross-clamp is removed. Conventional cross-clamps also require a large opening in the chest in order to gain access to the aorta, hindering any effort to reduce the trauma associated with the procedure.
  • What are needed, therefore, are devices and techniques for the surgical treatment of CHF which are less invasive and less risky than the Batista Operation, but which produce the benefits associated with reducing the volume of the left ventricle. The devices and techniques should facilitate the identification of an appropriate section of the left ventricular wall, excision or other reshaping of the section, and, if the section is removed, closure of the left ventricle, without requiring a gross thoracotomy or median sternotomy. If the left ventricle is opened, the devices and techniques should allow the patient to be placed on cardiopulmonary bypass and the heart to be arrested and isolated from the circulatory system without the need for an external aortic cross-clamp. Further, the devices and techniques should minimize that risk that either air and other emboli will be produced by the procedure.
  • SUMMARY OF THE INVENTION
  • The invention provides devices and methods for treating CHF, as well as other diseases resulting in an enlarged heart, that not only significantly reduce the pain and trauma to the patient, but that may reduce the risk of infection and the risk of neurological events associated with the Batista Operation. The invention facilitates the reduction of left ventricular volume by removing a section of the heart wall or otherwise reshaping the ventricle without requiring a median sternotomy or gross thoracotomy. The invention further allows the procedure to be performed on cardiopulmonary bypass with the heart isolated and arrested, yet without the gross thoracic incision required by, or the risk of embolism produced by, conventional aortic cross-clamps. Moreover, the invention may significantly reduce the risk that air will be introduced into the bloodstream and embolized to the brain during or after the procedure.
  • In a first embodiment, the invention provides a method of reshaping a patient's heart, comprising the steps of:
      • introducing an aortic occlusion catheter through a patient's peripheral artery, the aortic occlusion catheter having an occluding member movable from a collapsed position to an expanded position;
      • positioning the occluding member in the patient's ascending aorta;
      • moving the occluding member from the collapsed shape to the expanded shape after the positioning step;
      • introducing cardioplegic fluid into the patient's coronary blood vessels to arrest the patient's heart;
      • maintaining circulation of oxygenated blood through the patient's arterial system; and
      • reshaping an outer wall of the patient's heart while the heart is arrested so as to reduce the transverse dimension of the left ventricle.
  • The ascending aorta is preferably occluded by means of an occlusion balloon attached to the distal end of an elongated catheter positioned transluminally in the aorta from a femoral, subclavian, or other appropriate peripheral artery. Cardioplegic fluid may then be delivered upstream of the occlusion balloon through a lumen in that catheter, and/or delivered in a retrograde manner through a separate catheter placed transluminally into the coronary sinus from a peripheral vein. While the heart is arrested, circulation of oxygenated blood is maintained preferably by peripheral extraporeal cardiopulmonary bypass (CPB), wherein blood is removed from a peripheral vein via a venous drainage catheter, filtered, oxygenated, and returned to a peripheral artery through an arterial return catheter.
  • By obviating the need for an aortic cross-clamp, the need for the median sternotomy through which such a cross-clamp is placed is also eliminated. The left ventricle may then be reshaped and volumetrically reduced using thoracoscopic instruments positioned through small incisions, punctures or ports located in the intercostal spaces between the ribs.
  • The invention further provides a method of reshaping a patient's heart comprising the steps of:
      • introducing a tissue attaching device into the patient's chest;
      • engaging a first location on a wall of the left ventricle with the tissue attaching device; and
      • manipulating the tissue attaching device to attach the first location to a second location on a wall of the heart so as to reduce the transverse dimension of the left ventricle, the user's hands remaining outside the patient's chest when manipulating the tissue attaching device.
  • In some embodiments, a section of the left ventricular wall is excised with a cutting device, then the left ventricle is closed using sutures, staples or other means for wound approximation and closure, each applied using thoracoscopic instruments with the user's hands maintained generally outside of the chest. In other embodiments, a section of the left ventricular wall is gathered together or pursed outwardly or inwardly to produce one or more folds or pleats in the wall. These folds or pleats are then thoracoscopically sutured, stapled or otherwise fastened permanently in place to reduce the transverse dimension of the left ventricle.
  • In the method of the invention, the left ventricular wall may be approached in several different ways. In one approach, one or more small incisions, punctures, trocar sleeves, tissue retractors or other type of ports are placed in intercostal spaces in the left anterior and/or lateral side of the chest, preferably between the third and seventh intercostal spaces. This permits direct access to the outer wall of the left ventricle on the lateral and posterior sides of the heart, usually with minor retraction of the apex of the heart anteriorly using thoracoscopic graspers or other retraction instruments. The heart may then be viewed directly through an intercostal port, or by means of a thoracoscope positioned through an intercostal port to permit either direct or video-based viewing of the heart.
  • In a second approach, ports are placed are in the right lateral side of the chest between the third and seventh intercostal spaces. Approaching the heart from the right, an incision is then made in the left atrium on the posterior side of the heart, and the incision retracted to expose the mitral valve. The mitral valve apparatus is excised from the heart, providing access into the interior of the left ventricle through the mitral valve annulus. A thoracoscopic scissors or knife is then used to excise a portion of the left ventricular wall from the inside of the chamber, either under direct vision from a port in the right side of the chest, or under video-based vision using a thoracoscope positioned through a port into the heart. The procedure may be viewed from outside of the heart as well by placing a thoracoscope through a port in the left lateral or anterior side of the chest. The left ventricular wall may then be closed using sutures, staples, or other means applied with an instrument introduced through the mitral annulus from the right chest, or through a port placed in the left lateral or anterior side of the chest as described above.
  • In still other embodiments, a restrictive girdle or band is placed around the outside of the heart to restrict the left ventricle to the desired diameter or volume. The band or girdle is preferably elastic so as to expand and contract with the heart as it pumps. Preferably, the girdle or band is applied to the heart using specialized thoracoscopic instruments placed through intercostal spaces in the rib cage while generally maintaining the user's hands outside the chest, thereby eliminating the need for a gross thoracotomy.
  • Because the chest is not grossly opened, the heart is isolated from the rest of the circulatory system, and in some embodiments, even the ventricle itself is not opened, the methods of the invention may reduce the risk that air will pass through the ventricular incision and into the bloodstream. To reduce this risk even further, the invention also allows the chest to be flooded with carbon dioxide or other suitable gas during the procedure to maintain the chest cavity free of air. A tube may be placed through one of the intercostal ports and gas delivered through the tube into the chest at a pressure suitable to ensure that air cannot enter the chest cavity. Additionally, trocar sleeves or tubular ports may be used which have internal seals like those used for gaseous insufflation in laparoscopic procedures, thereby preventing the unwanted introduction of air into the chest. Further, where some risk of air embolism is present due to the opening of the left ventricle, following closure the left ventricle and aorta may be flushed with saline and then vented through a lumen in the aortic occlusion catheter while maintaining aortic occlusion, thereby removing any trapped air that may be present.
  • The nature and advantages of the invention will become more apparent in he following detailed description, taken in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an anterior view of a patient's torso schematically illustrating the use of an endovascular cardiopulmonary bypass system according to the invention.
  • FIG. 2 is an anterior view of a patient's chest illustrating the placement of intercostal ports and thoracoscopic instruments according to the invention.
  • FIGS. 3-5 are posterior views of a patient's heart illustrating the removal of a section of the left ventricle and closure of the left ventricular wall according to the invention.
  • FIG. 6A is a transverse cross-section of a patient's chest illustrating an alternative approach to the left ventricle according to the invention.
  • FIG. 6B is a transverse cross-section of a patient's chest illustrating an alternative method of ventricular volume reduction according to the invention.
  • FIGS. 6C-6D are close-up cross-sections of the ventricular wall illustrating additional steps in the method of FIG. 6B.
  • FIGS. 7A-7B are transverse cross-sections of a patient's heart before and after treatment, respectively, illustrating the bifurcation of the left ventricle according to the invention.
  • FIG. 7C is a posterior view of a patient's heart illustrating the exterior shape of the left ventricle after bifurcation as in FIG. 7B.
  • FIG. 8A is a side view of a tissue gathering device according to the invention.
  • FIG. 8B is a top view of the distal end of the tissue gathering device of FIG. 8A.
  • FIG. 9A is a cross-section of a portion of the left ventricle illustrating the use of the tissue gathering device of FIG. 8A according to the method of the invention.
  • FIG. 9B is a posterior view of a patient's heart illustrating the heart after treatment using the tissue gathering device of FIG. 8A.
  • FIG. 10 is a posterior view of a patient's heart illustrating the use of a heart measurement device according to the invention.
  • FIG. 11 is a transverse cross-section of a patient's thorax illustrating the use of a left ventricular measurement device according to the invention.
  • DESCRIPTION OF THE SPECIFIC EMBODIMENTS
  • Referring to FIG. 1, an endovascular cardiopulmonary bypass (CPB) system useful in the method of the invention is illustrated as it is used in a patient. Additional aspects of such endovascular CPB systems suitable for use in the methods of the invention are described in the following patent applications, which are incorporated herein by reference: Ser. No. 08/282,192, filed Jul. 28, 1994, now U.S. Pat. No. 5,584,803, Ser. No. 08/612,341, filed Mar. 7, 1996, and Ser. No. 08/486,216, filed Jun. 7, 1995, now U.S. Pat. No. 5,766,151. The system includes a venous drainage cannula 20 placed into a femoral vein FV (or other suitable peripheral vein) and preferably having sufficient length to extend into the inferior vena cava IVC, the right atrium RA or the superior vena cava SVC. Venous drainage cannula 20 is connected to an extracorporeal CPB system 22, which filters and oxygenates the blood withdrawn from the patient. The system further includes an arterial return cannula 24 placed into a femoral artery FA (or other peripheral artery such as the subclavian) through which CPB system 22 pumps oxygenated blood into the arterial system. Arterial return cannula 24, venous drainage cannula 20 and CPB system 22 are configured to provide full cardiopulmonary bypass with the patient's heart arrested.
  • The endovascular CPB system further includes an aortic occlusion catheter 26 that is positioned into femoral artery FA through a port 28 at the proximal end of arterial return cannula 24. Port 28 has a hemostatic seal (not shown) to prevent blood loss when occlusion catheter 26 is positioned through the port. Occlusion catheter 26 has an occlusion balloon 30 at its distal end and a length sufficient to allow occlusion balloon 30 to be positioned in the ascending aorta AA, usually at least about 80 cm. Occlusion catheter 26 preferably has at least three lumens, including an inflation lumen in communication with the interior of balloon 30 for delivery of an inflation fluid from a syringe 32 or other inflation device. A pressure lumen is also provided which communicates with a pressure port in the catheter distal to balloon 30, allowing pressure to be monitored by means of a pressure measuring device 34. Occlusion catheter 26 further includes a main lumen in communication with an additional port distal to balloon 30 to allow delivery of cardioplegic fluid from a cardioplegic fluid source 36 and to facilitate venting the aortic root by means of a suction pump 38. A two-way valve 40 permits selecting between cardioplegic fluid delivery or aortic root venting via the main lumen.
  • An optional component of the endovascular CPB system is a coronary sinus catheter 42 positioned transluminally into the coronary sinus CS via the internal jugular vein JV in the neck, the superior vena cava SVC, and right atrium RA. Coronary sinus catheter 42 permits retrograde delivery of cardioplegic fluid in conjunction with or instead of antegrade delivery through aortic occlusion catheter 26. The distal end of catheter 42 includes a balloon 44 configured to occlude the coronary sinus CS. Sinus catheter 42 has at least two lumens, including an inflation lumen in communication with balloon 44, and a delivery lumen in communication with a port distal to balloon 44 for delivering cardioplegic fluid into coronary sinus CS. A third lumen may optionally be provided for pressure measurement through a port distal to balloon 44.
  • As an additional option, an endovascular venting catheter may be introduced into a vein in the neck and advanced through the superior vena cava, the right atrium, the right ventricle and into the pulmonary artery for venting blood from the heart, as described in co-pending application Ser. No. 08/415,238, filed Mar. 30, 1995, which is incorporated herein by reference.
  • In use, with venous drainage cannula 20 and arterial return cannula 24 in place and blood circulating through extracorporeal CPB system 22, aortic occlusion catheter 26 is inserted through arterial return cannula 24 and slidably advanced toward the heart until occlusion balloon 30 is in the ascending aorta AA. Balloon 30 is then inflated to fully occlude the aortic lumen between the coronary ostia (not shown) and the brachiocephalic artery BA. Cardioplegic fluid, usually consisting of a cold potassium chloride solution mixed with oxygenated blood, is then delivered into the ascending aorta through the main lumen of occlusion catheter 26, from which it flows into coronary arteries and perfuses the myocardium, stopping cardiac contractions. If coronary sinus catheter 42 is utilized, balloon 44 may be inflated and cardioplegic fluid delivered into the coronary sinus CS, from which it flows through the coronary veins to perfuse the myocardium. Between periodic infusions of cardioplegic fluid, valve 40 is switched to allow the aortic root to be vented of fluid via occlusion catheter 26. Aortic root pressure may be continuously monitored using pressure measurement device 34.
  • Prior to arresting the heart, it may be desirable to perform a number of surgical steps in the operation up to the point of actually cutting into the myocardium so as to minimize the time for which the heart is stopped. A number of surgical ports 50, usually between about one and six, are placed in intercostal spaces IS between the ribs R. These ports may be simple plastic tubes having flanges at their proximal ends to prevent passage entirely into the chest and having sufficient rigidity to retract intercostal tissue so as to form an opening. Trocar sleeves or small bladed rib retractors may also be used. A soft tissue retractor that may be particularly useful in the method of the invention is described in application Ser. No. 08/610,619, filed Mar. 4, 1996, now U.S. Pat. No. 5,810,721, which is incorporated herein by reference. In some cases, instruments may be placed directly through incisions or punctures between the ribs without any type of retraction. In any case, all of the aforementioned means of access into the chest will be referred to herein as ports.
  • Ports 50 may be positioned in any of several regions of the chest, depending upon the desired approach to heart. For approaching the left ventricle on the posterior side of the heart, ports 50 are preferably placed in the fourth, fifth, sixth or seventh intercostal spaces on the left anterior and/or left lateral side of the patient's chest. For approaching the left ventricle from within the heart via the left atrium and the mitral valve, ports 50 are placed in the right lateral side of the chest in the second, third, fourth, fifth, or sixth intercostal spaces. Of course, it will be understood that the exact location of ports 50 will depend upon the location of the surgical site on the heart, individual patient anatomy, and surgeon preference.
  • One or both of the patient's lungs may have to be partially or fully collapsed during the procedure in order to gain access to the heart. With the lungs collapsed, the pericardium PC is incised, as illustrated in FIG. 2, using thoracoscopic scissors 52, an electrocautery probe or other appropriate cutting devices, along with graspers 54 or other retraction devices, inserted through ports 50. Suitable instruments are described in U.S. Pat. No. 5,501,698, which is incorporated herein by reference. A thoracoscope 56 is inserted through one of ports 50 to facilitate visualization. Thoracoscope 56 includes a camera 58 which produces a video image of the interior of the chest that can be viewed on a video monitor (not shown). Various conventional thoracoscopes may be used, including the articulating Welch-Allyn DistalView 360 (Welch-Allyn, Skaneateles Falls, N.Y.), or a 30□ angled endoscope available from Olympus Optical (Lake Success, N.Y.). The surgeon may also look directly into the chest through ports 50, assisted by illumination of the chest by means of a light probe inserted through a port. The pericardium is opened or removed from around the left ventricle to expose the surgical site.
  • In a first embodiment of the ventricular volume reduction procedure of the invention, a portion of an outer wall of the left ventricle is removed and the wall then reclosed so as to reduce the traverse dimension and volume of the ventricular chamber. Referring to FIG. 3, a posterior view of the heart, with the patient's heart arrested and circulation maintained by CPB system 22, a cutting device such as a knife 60 along with thoracoscopic graspers 62 are inserted though ports 50 and used to excise the desired portion of the ventricular wall. During the procedure some retraction of the heart may be required, by for example, grasping the apex of the heart with graspers 62 and moving the apex anteriorly so as to expose the posterior aspect of the left ventricle. Using knife 60, a stab wound is made near the apex AP of the heart and an incision extended superiorly toward the left atrium in an arc bowing outwardly toward the left side of the heart. A second incision is made from the apex in an opposing arc bowing outwardly toward the right side of the heart and intersecting the first incision near the coronary sinus CS, allowing a football-shaped section of myocardial tissue to be removed. This leaves an opening OP in the left ventricular wall as illustrated in FIG. 4.
  • Opening OP is then sutured closed using thoracoscopic needle drivers 64 to drive curved needle 66 and suture 68 through ventricular wall VW and using graspers 62 to assist in approximating the opposing edges of the opening. Usually a relatively coarse running stitch is placed in the wall to draw opening OP closed, and a finer running stitch is then applied to ensure the wound is hemostatically sealed.
  • The exact location and amount of tissue removed from the left ventricular wall will vary according to the type and severity of disease and other factors. The effectiveness of the heart in pumping blood will generally be increased by reducing the transverse dimension of the left ventricle so as to reduce the overall volume of the chamber. This allows less blood to flow into the left ventricle before each contraction, thereby reducing the outward force of the blood against the ventricle when it contracts. Preferably, a sufficiently large section of the ventricular wall will be removed to reduce the ventricle to having a transverse dimension (generally perpendicular to the interventricular septum) on the order of 4 to 7 cm.
  • Generally, opening OP in the left ventricular wall will be formed between the anterior and posterior papillary muscles, avoiding unnecessary damage to the mitral valve apparatus. In some cases, however, the mitral valve apparatus is damaged or removed during the procedure, requiring replacement or repair of the valve following removal of the ventricular wall section. This may be accomplished by introducing an annuloplasty ring or prosthetic valve into the heart through ports 50 and opening OP and securing the prosthesis at the mitral valve position using thoracoscopic instruments introduced through ports 50. Alternatively, the mitral valve may be replaced via ports in the right lateral side of the chest by entering the left atrium, using the techniques described in co-pending application Ser. No. 08/465,383, filed Jun. 5, 1995, now U.S. Pat. No. 5,682,906, which is hereby incorporated herein by reference.
  • Following closure of the left ventricular wall, ports 50 are removed and thoracic incisions are closed. Cardioplegic fluid infusions are discontinued and the aortic root is vented through occlusion catheter 26 to remove any air or other particles which may be present in the heart or aorta. If desired, saline may be delivered through the main lumen of the occlusion catheter into the aortic root, or a small catheter may be advanced through the occlusion catheter and into the left atrium through the aortic valve to deliver saline into the left ventricle. The heart may be compressed using thoracoscopic probes to urge air out of the left ventricle. The saline is then vented through occlusion catheter 26 to remove air and other emboli. In order to restart heart contractions, occlusion balloon 30 on aortic occlusion catheter 26 is deflated to allow blood from arterial return cannula 24 to reach the coronary ostia. If cardiac contractions do not resume spontaneously, an electric shock may be delivered to the heart using thoracoscopic or external defibrillation paddles. When the heart is in sinus rhythm, the patient is weaned from cardiopulmonary bypass, vascular punctures are closed, and the patient recovered from general anesthesia.
  • Because the left ventricle is opened during the procedure, it will be desirable to keep air out of the chest cavity to the maximum extent until the ventricle is closed. For this purpose, ports 50 may be provided with gaseous seals like those used in laparoscopic trocar sleeves to maintain an air-free environment within the chest. In addition, a gas such as carbon dioxide that is not likely to embolize in the blood stream may be delivered into the chest at a sufficient rate and pressure to prevent air from entering. Other techniques for preventing air embolism are described in co-pending application Ser. No. 08/585,871, filed Jan. 12, 1996, now U.S. Pat. No. 5,849,005 which is incorporated herein by reference.
  • FIG. 6A-6D are transverse cross-sections of a patient's thorax and heart illustrating additional embodiments of the method of the invention. In these embodiments, a right chest approach is used similar to that described in co-pending application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, which has been incorporated herein by reference. That application describes techniques for opening the pericardium, forming and retracting an atrial incision, removing the mitral valve, and implanting a valve prosthesis which may be utilized in the method of the present invention.
  • Preferably, ports 50A are placed in the second, third, fourth, fifth, or sixth intercostal spaces in the right lateral side of the chest. Optionally, additional ports 50B may be placed in the left lateral or left anterior sides of the chest to approach the left ventricle on the posterior side of the heart, as described above with reference to FIGS. 1-2. An opening is first formed in the pericardium using thoracoscopic instruments inserted through right chest ports 50A and/or left chest ports 50B so as to expose the left atrium LA and the left ventricle LV. A thoracoscope 70 may be inserted through one of ports 50A to view the interior of the chest, or the surgeon may view the chest cavity directly by looking through ports 50A. If desired, one or more of ports 50A may be configured to provide a wider opening into the chest to allow greater maneuverability of instruments and to facilitate direct vision into the chest, such as the oval-shaped port described in application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, or the soft tissue retractor described in application Ser. No. 08/610,619, now U.S. Pat. No. 5,810,721, referenced above. Preferably, these will not require cutting or removing the ribs, and will minimize any retraction of the ribs, although in some cases it may be desirable to retract the ribs slightly or remove a small portion of a rib to provide greater access into the chest. However, ports 50A will generally not be large enough to allow the surgeon's hands to be placed into the chest, although it may be possible to place one or more individual fingers into the chest.
  • The right lung is collapsed, the pericardium is opened and the patient is on CPB with the heart arrested as described above. An incision is made in the left atrium on the right lateral/posterior aspect of the heart using thoracoscopic scissors or knife inserted through a port 50A. The atrial incision is then retracted anteriorly using a thoracoscopic retractor 72. Suitable retractors are described in co-pending application Ser. No. 08/577,547, filed Dec. 22, 1995 which is hereby incorporated herein by reference. With the atrial incision retracted in this manner, the mitral valve is exposed at a direct line of sight from a port 50A in the fourth, fifth, or sixth intercostal space in the right chest. The mitral valve leaflets may then be removed using thoracoscopic scissors so that the left ventricle LV is visible through the mitral valve annulus VA. The valve leaflets and chordae tendonae may alternatively be left intact, and a thoracoscope introduced through the valve into left ventricle LV to provide visualization within the chamber.
  • In the embodiment shown in FIG. 6A, a section of the left ventricular wall VW is then removed using elongated thoracoscopic scissors 74 or other suitable cutting device introduced through a port 50A and valve annulus VA. Scissors 74 are used to excise a football-shaped section of ventricular wall tissue, preferably between the anterior and posterior papillary muscles. An additional thoracoscope 76 may be introduced through left lateral chest ports 50B with the left lung collapsed to visualize the outer wall of the left ventricle to ensure the desired section is removed without cutting into adjacent tissues.
  • The left ventricular wall is then closed in one of two ways. Ventricular wall VW may be sutured from within the chamber with thoracoscopic needle drivers introduced through right chest ports 50A and mitral valve annulus VA, or sutured from outside the heart using needle drivers inserted through left chest ports 50B as described above in connection with FIG. 5. Advantageously, should the mitral valve require repair or replacement after the ventricular wall has been closed, excellent access is provided through right chest ports 50A to implant either a replacement valve or an annuloplasty ring, or perform any necessary surgical repair of the valve, in the manner described in co-pending application Ser. No. 08/465,383, now U.S. Pat. No. 5,682,906, already incorporated herein by reference. The left atrium is then closed. Ports 50A, 50B are removed and thoracic incisions are closed. The heart is restarted and the patient is weaned from cardiopulmonary bypass as described above.
  • In an alternative embodiment, shown in FIGS. 6B-6D, rather than cutting entirely through the heart wall to remove a section of the wall, a section of the inner wall of the heart is removed while leaving a thin layer of the outer wall intact. For this purpose, a thoracoscopic tissue-removing instrument 61, such as an end-biting biopsy or rongeur type instrument, may be utilized which has a pair of pivotable jaws 63 with tissue-cutting cup-shaped tips 65 that interact in a shearing relationship to bite off a portion of tissue, as shown in FIG. 6C. A variety of other conventional endoscopic tissue removal instruments may also be used. In this way, a very thin section of the ventricular wall is created in the area which would otherwise be removed according to the alternative methods described above. Ventricular wall VW is then drawn together and sutured so that the thin section of the wall is pursed outward, as shown in FIG. 6D. A thoracoscopic needle driver 67 may be inserted through a right chest port 50A and through the mitral valve to apply a suture 69, or a needle driver may be inserted through a left lateral or anterior port 50B to apply sutures from the exterior of the heart. In some cases, it may be desirable to progressively draw the heart wall closer and closer together, by first drawing together only a portion of the thin-walled section and suturing it in place, then drawing together a wider portion, suturing it, and repeating the process until the entire thin-walled section has been folded together and the ventricle is of the desired dimension.
  • FIGS. 7A-7C illustrate a further embodiment of the method of the invention. In this embodiment, rather than removing a section of the left ventricle, the ventricle is reshaped by attaching a central longitudinal section of the ventricular wall VW to the interventricular septum IS. This is most readily accomplished by inserting a thoracoscopic tissue attachment device through left chest ports 50B (FIG. 2), exerting inward pressure against the left ventricular wall VW until it abuts septum IS, and securing wall VW to septum IS. The tissue attachment device comprises, in an exemplary embodiment, an insertion device 71 for applying a T-shaped fastener like that described in reissued U.S. Pat. No. Re34,021, incorporated herein by reference. Insertion device 71 has a tubular shaft 73 with a sharpened distal end 75 used to penetrate ventricular wall VW and interventricular septum IS. A suture 77 is attached to a central portion of a fastener 80 (not shown in FIG. 7A) which is removably positioned in tubular shaft 73 during insertion. A second suture 79 is also attached to an end of fastener 80 for removal purposes, as described in the aforementioned reissue patent. Once distal end 75 has penetrated system IS, an obturator (not shown) is positioned through tubular shaft 73 so as to deploy fastener 80 into the right ventricle RV. Insertion device 71 is then removed from the heart, leaving sutures 77,79 extending through the septum IS and ventricular wall VW. A retainer 81, slidably mounted on sutures 77,79, is then advanced against ventricular wall VW to urge the ventricular wall against septum IS, as shown in FIG. 7B. A series of fasteners 80 are applied in this way along a generally vertical line extending from the apex of the heart toward the superior aspect of the heart so as to bifurcate the ventricle into two separate chambers communicating with each other and with the aortic valve AV and mitral valve MV at the superior end of the chambers. Each of the smaller chambers thus created has a smaller transverse dimension and volume than the left ventricle, and the contraction of each chamber is therefore opposed by a smaller outward force from blood present in the chamber than that to which the single larger ventricle is subject. It will be understood that a variety of tissue attachment techniques may be used instead of the T-shaped fastener illustrated, including suturing by means of a large curved needle and thoracoscopic needle drivers, or skin or fascia type staplers. A particular advantage of this technique is that it does not require the left ventricle to be opened and exposed to air, thereby eliminating the risk of air embolism resulting from the procedure. Additionally, the technique avoids any loss of blood from the ventricle, allowing it to be performed on the beating heart, without occluding the aorta, arresting the heart, or placing the patient on CPB.
  • A further embodiment of a method of ventricular volume reduction will now be described in connection with FIGS. 8A-8B and 9A-9B. In this embodiment, a thoracoscopic tissue gathering device is utilized, an exemplary embodiment of which is illustrated in FIGS. 8A-8B. Tissue gathering device 84 comprises an elongated tubular shaft 86 and an inner rod 88 extending slidably through shaft 86. A tissue engaging member 90 is attached to the distal end of rod 88. Tissue engaging member 90 comprises a pair of jaws 92 biased away from each other and connected at their proximal ends to rod 88. The lateral surfaces 94 of jaws 92 are engaged by the inner wall of shaft 86 such that sliding the shaft distally relative to rod 88 urges jaws 92 toward one another. A plurality of sharp points or teeth 96 extend inwardly from a distal portion of jaws 92 and are configured to penetrate the ventricular wall, as described below. Jaws 92 may be as narrow as the diameter of shaft 86 or even narrower, if desired, with only one or two opposing teeth 96, but are preferably somewhat wider as illustrated, e.g. 1-5 cm in width (transverse to shaft 86), with three or more teeth 96 on each jaw, to facilitate gathering a wide section of tissue between them. The distal transverse portion 97 of jaws 92 on which teeth 96 are disposed is preferably arcuate in shape to facilitate grasping a curved section of tissue between the jaws.
  • A handle 98 is attached to the proximal end of shaft 86 and includes a stationary handle member 100 having finger loops 101 and a movable handle member 102 pivotably attached to stationary handle member 100 and having thumb loop 103. The proximal end of rod 88 is attached to movable handle member 102 such that pivoting the movable handle member toward the stationary handle member pulls rod 88 proximally relative to shaft 86, thereby closing jaws 92. A locking mechanism 104 facilitates maintaining the jaws in the closed position without maintaining pressure on handle 100.
  • The use of tissue gathering device 84 in the method of the invention is illustrated in FIGS. 9A-9B. Tissue gathering device 84 is introduced through a port 50B (FIG. 2) in the left lateral or anterior side of the chest selected to allow access to the left ventricle on the posterior side of the heart near the apex. The heart may be retracted as necessary to facilitate access and visualization of the left ventricle either directly or by means of a thoracoscope. Jaws 92 are positioned in the open position against the ventricular wall VW and closed so as to gather a section of ventricular wall tissue between the jaws, as illustrated in FIG. 9A. Usually this will be an arcuate section of tissue extending from a point near the apex superiorly along the left ventricle on the posterior side of the heart. Points 96 penetrate the outer surface of the ventricular wall to facilitate grasping the wall tissue and pursing it outwardly between the jaws. Locking mechanism 104 on handle 100 may then be engaged so as to lock jaws 92 in position, thereby maintaining the gathered section of ventricular wall tissue between jaws 92.
  • The opposing halves of the folded section of wall tissue are then attached to one another near the base of the fold, using a large arcuate needle 108 attached to a suture 110, driven by a thoracoscopic needle driver 112 inserted through a port 50. A running stitch may be applied, or a series of individual suture loops. Alternatively, a thoracoscopic stapler, T-fastener applier, or other suitable tissue fastening device may be used. The result is shown in FIG. 9B. A large section FS of left ventricle LV has been folded outwardly and isolated from the remainder of the ventricle thereby reducing the transverse dimension and volume of the ventricle. If desired, the outer portion of the folded section FS may be cut off and removed using a thoracoscopic scissors or knife. Advantageously, as in the embodiment described above in reference to FIGS. 7A-7C, the left ventricle is not opened during the procedure, eliminating the risk of air embolism, and avoiding blood loss, thus allowing the procedure to be performed on a beating heart without cardiac arrest and CPB.
  • In any of the embodiments of the invention described herein it may desirable to more accurately measure the size of the left ventricle to allow a more precise determination of the amount by which the left ventricle must be reduced. FIGS. 10 and 11 illustrate two alternative embodiments for measuring left ventricular size. In FIG. 10, a thoracoscopic heart measurement device 120 comprises a shaft 122 configured for insertion through a thoracic port between the ribs, and a flexible band 124 extending from the distal end of the shaft to form a loop. Band 124 may be made of a flexible polymer or metal, and extends slidably through an inner lumen in shaft 122 so that the size of the loop may be contracted or expanded by extending or retracting band 124 from the distal end of the shaft. In this way, the loop may be placed around the exterior of the heart H and cinched against the outer wall of the heart. Measurement device 120 is then removed from the chest while maintaining the size of the loop, which may then be measured outside the chest to determine the circumference or diameter of the heart.
  • An alternative embodiment of a ventricular measurement device 130 is illustrated in FIG. 11. Ventricular measurement device 130 includes a shaft 132 positionable through a right chest port 50A, through a left atrial incision, through the mitral valve, and into the left ventricle LV. Shaft 132 therefore has a length of at least about 20 cm, and usually about 25-40 cm. An elastomeric balloon 134 is attached to the distal end of shaft 132 and has an interior in communication with an inflation lumen extending through shaft 132. An inflation device such as a syringe 136 is attached to the proximal end of shaft 132 in communication with the inflation lumen to facilitate delivery of an inflation fluid into balloon 134. Balloon 134 is of a size large enough to completely occupy the left ventricle, preferably being inflatable to a diameter of 4-12 cm. In this way, measurement device 130 may be introduced into the left ventricle via the left atrium and mitral valve and balloon 134 expanded until it engages the inner ventricular wall. By observing the volume of inflation fluid required to expand the balloon to this size, the approximate volume of the left ventricle may be assessed. In an alternative embodiment, a penetration may be made in the wall of the left ventricle via a port in the left lateral or anterior side of the chest, and balloon 134 inserted directly through the penetration to measure left ventricular volume. A purse string suture may be placed in the heart wall around the penetration to maintain hemostasis around shaft 132.
  • While the above is a complete description of the preferred embodiments of the invention, it will be understood that various substitutions, modifications, alternatives, and additions will be possible without departing from the scope of the invention, which is defined by the appended claims.

Claims (21)

1. A method of reshaping a patient's heart comprising:
gauging the size of the left ventricle;
determining the amount by which the left ventricle should be reduced from the gauging of its size; and
reducing the dimension of the left ventricle in accordance with the determined amount.
2. The method according to claim 1, wherein gauging the size of the left ventricle comprises encircling the heart closely with an adjustable length band, and determining the size of the ventricle with reference to the length of the band.
3. The method according to claim 1, wherein gauging the size of the left ventricle comprises inserting an expansible member into the left ventricle, and expanding the expansible member.
4. The method according to claim 3, wherein the expansible member is a balloon, and expanding the balloon is accomplished by the introduction of fluid into an interior of the balloon.
5. The method according to claim 4, wherein gauging the size of the left ventricle further comprises measuring the volume of fluid introduced into the interior of the balloon.
6. The method according to claim 1, wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.
7. The method according to claim 6, wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.
8. The method according to claim 6, wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.
9. The method according to claim 6, wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.
10. A method of reshaping a patient's heart comprising:
introducing an expansible member into the left ventricle of a patient's heart, the expansible member being at least partially collapsed;
expanding the expansible member within the left ventricle of a patient's heart; and
reducing the volume of the left ventricle by an amount based upon the expanded volume of the expansible member.
11. The method according to claim 10, wherein the amount of volume reduction of the patient's left ventricle is determined by the expanded volume of the expansible member compared to a desired volume of the left ventricle.
12. The method according to claim 10, wherein expanding the expansible member comprises the introduction of fluid into the interior of the expansible member.
13. The method according to claim 10, wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.
14. The method according to claim 13, wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.
15. The method according to claim 13, wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.
16. The method according to claim 13, wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.
17. A method of reshaping a patient's heart comprising:
encircling the heart closely with an adjustable length band;
determining the size of the left ventricle with reference to the length of the band; and
reducing the volume of the left ventricle by an amount based upon the determined size of the left ventricle.
18. The method according to claim 13, wherein reducing the dimension of the left ventricle comprises creating an opening the in the left ventricular wall.
19. The method according to claim 13, wherein reducing the dimension of the left ventricle further comprises removing a portion of the myocardial tissue.
20. The method according to claim 13, wherein creating an opening the in the left ventricular wall comprises creating perforation in the left ventricle extending to the apex of the heart.
21. The method according to claim 13, wherein reducing the dimension of the left ventricle further comprises hemostatically closing the left ventricle.
US11/729,165 1993-02-22 2007-03-28 Minimally-invasive devices and methods for treatment of congestive heart failure Abandoned US20080029105A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/729,165 US20080029105A1 (en) 1993-02-22 2007-03-28 Minimally-invasive devices and methods for treatment of congestive heart failure

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/023,778 US5452733A (en) 1993-02-22 1993-02-22 Methods for performing thoracoscopic coronary artery bypass
US08/163,241 US5571215A (en) 1993-02-22 1993-12-06 Devices and methods for intracardiac procedures
US28196294A 1994-07-28 1994-07-28
US48560095A 1995-06-07 1995-06-07
US08/685,262 US6125852A (en) 1993-02-22 1996-07-23 Minimally-invasive devices and methods for treatment of congestive heart failure
US09/950,917 US20020029783A1 (en) 1993-02-22 2001-09-12 Minimally-invasive devices and methods for treatment of congestive heart failure
US10/665,236 US7213601B2 (en) 1993-02-22 2003-09-17 Minimally-invasive devices and methods for treatment of congestive heart failure
US11/729,165 US20080029105A1 (en) 1993-02-22 2007-03-28 Minimally-invasive devices and methods for treatment of congestive heart failure

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/665,236 Continuation US7213601B2 (en) 1993-02-22 2003-09-17 Minimally-invasive devices and methods for treatment of congestive heart failure

Publications (1)

Publication Number Publication Date
US20080029105A1 true US20080029105A1 (en) 2008-02-07

Family

ID=46299976

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/665,236 Expired - Fee Related US7213601B2 (en) 1993-02-22 2003-09-17 Minimally-invasive devices and methods for treatment of congestive heart failure
US11/729,165 Abandoned US20080029105A1 (en) 1993-02-22 2007-03-28 Minimally-invasive devices and methods for treatment of congestive heart failure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/665,236 Expired - Fee Related US7213601B2 (en) 1993-02-22 2003-09-17 Minimally-invasive devices and methods for treatment of congestive heart failure

Country Status (1)

Country Link
US (2) US7213601B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090287183A1 (en) * 2008-05-14 2009-11-19 Onset Medical Corporation Expandable transapical sheath and method of use
US20110024614A1 (en) * 2006-10-19 2011-02-03 Syft Technologies Limited Sift-ms instrument
US20110144690A1 (en) * 2008-05-14 2011-06-16 Onset Medical Corporation Expandable transapical sheath and method of use
US8109995B2 (en) 2002-01-04 2012-02-07 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8361144B2 (en) 2010-03-01 2013-01-29 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US20150089428A1 (en) * 2013-09-24 2015-03-26 Microsoft Corporation Quick Tasks for On-Screen Keyboards
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US20040260278A1 (en) * 1996-10-22 2004-12-23 Anderson Scott C. Apparatus and method for ablating tissue
US7052493B2 (en) * 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6719755B2 (en) * 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US8709007B2 (en) * 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
CA2377583A1 (en) * 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US7441342B2 (en) * 2001-04-24 2008-10-28 Chf Technologies, Inc. System and method for sizing a heart for treating congestive heart failure
US20070293855A1 (en) * 2002-02-15 2007-12-20 Sliwa John W Jr Methods and devices for ablation
WO2006034408A2 (en) * 2004-09-23 2006-03-30 Chf Technologies, Inc. System and method for sizing a heart for treating congestive heart failure
WO2007130724A2 (en) * 2006-02-06 2007-11-15 Northwind Ventures Systems and methods for volume reduction
US9314298B2 (en) * 2007-04-17 2016-04-19 St. Jude Medical, Atrial Fibrillation Divisions, Inc. Vacuum-stabilized ablation system
WO2010071810A1 (en) 2008-12-19 2010-06-24 Andy Christopher Kiser Methods and devices for endoscopic access to the heart
AU2010229764B2 (en) * 2009-03-27 2015-05-07 Mardil, Inc. Intra-operative heart size measuring tool
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
US9445899B2 (en) 2012-08-22 2016-09-20 Joseph M. Arcidi Method and apparatus for mitral valve annuloplasty
US10632247B1 (en) * 2014-01-23 2020-04-28 Clph, Llc Apparatus, systems, and methods for delivering agents into a patient's body
US10542996B2 (en) 2017-06-27 2020-01-28 Covidien Lp Vessel closure device
US11278274B2 (en) 2018-05-04 2022-03-22 Arch Day Design, Llc Suture passing device
US10646217B2 (en) * 2018-05-04 2020-05-12 Arch Day Design, Llc Suture passing device
US11583269B2 (en) 2018-05-04 2023-02-21 Arch Day Design, Llc Suture passing device
US11246586B2 (en) 2019-08-20 2022-02-15 Arch Day Design, Llc Instrument to manipulate and pass suture
US10987456B2 (en) * 2019-09-23 2021-04-27 Synecor Llc Devices for use in extracting percutaneous ventricular assist devices
US20230218284A1 (en) * 2022-01-11 2023-07-13 Ryan Park Inflatable balloon retractor with pressure sensing and feedback capabilities for avoidance of excess applied pressure in brain surgery

Citations (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409013A (en) * 1965-08-23 1968-11-05 Berry Henry Instrument for inserting artificial heart valves
US3779234A (en) * 1971-06-30 1973-12-18 Intersc Res Inst Ultrasonic catheter with rotating transducers
US3827115A (en) * 1972-02-22 1974-08-06 Univ Erasmus Method of manufacturing a catheter
US3938502A (en) * 1972-02-22 1976-02-17 Nicolaas Bom Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves
US4042979A (en) * 1976-07-12 1977-08-23 Angell William W Valvuloplasty ring and prosthetic method
US4173981A (en) * 1977-05-23 1979-11-13 University Of Utah Cannula for arterial and venous bypass cannulation
US4192293A (en) * 1978-09-05 1980-03-11 Manfred Asrican Cardiac assist device
US4261342A (en) * 1978-10-26 1981-04-14 Iker Aranguren Duo Process for installing mitral valves in their anatomical space by attaching cords to an artificial stent
US4349033A (en) * 1980-11-06 1982-09-14 Eden Robert D Intrauterine catheter
US4372293A (en) * 1980-12-24 1983-02-08 Vijil Rosales Cesar A Apparatus and method for surgical correction of ptotic breasts
US4409974A (en) * 1981-06-29 1983-10-18 Freedland Jeffrey A Bone-fixating surgical implant device
US4536893A (en) * 1982-03-03 1985-08-27 Roberto Parravicini Implant device for substaining the activity of the myocardium
US4624671A (en) * 1984-06-25 1986-11-25 Kress Donald W Method of sizing and implanting breast prosthesis
US4655218A (en) * 1985-10-23 1987-04-07 Blagoveschensky Gosudarstuvenny Meditsinsky Institut Prosthetic valve holder
US4690134A (en) * 1985-07-01 1987-09-01 Snyders Robert V Ventricular assist device
US4705040A (en) * 1985-11-18 1987-11-10 Medi-Tech, Incorporated Percutaneous fixation of hollow organs
US4808163A (en) * 1987-07-29 1989-02-28 Laub Glenn W Percutaneous venous cannula for cardiopulmonary bypass
US4936857A (en) * 1987-02-23 1990-06-26 Kulik Yaroslav P Prosthetic pericardium
US4944753A (en) * 1988-09-26 1990-07-31 Burgess Frank M Method for producing retro-sternal space
US4960424A (en) * 1988-06-30 1990-10-02 Grooters Ronald K Method of replacing a defective atrio-ventricular valve with a total atrio-ventricular valve bioprosthesis
US4997431A (en) * 1989-08-30 1991-03-05 Angeion Corporation Catheter
US5011469A (en) * 1988-08-29 1991-04-30 Shiley, Inc. Peripheral cardiopulmonary bypass and coronary reperfusion system
US5032128A (en) * 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US5041130A (en) * 1989-07-31 1991-08-20 Baxter International Inc. Flexible annuloplasty ring and holder
US5104393A (en) * 1989-08-30 1992-04-14 Angelase, Inc. Catheter
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
USRE34021E (en) * 1985-11-18 1992-08-04 Abbott Laboratories Percutaneous fixation of hollow organs
US5169381A (en) * 1991-03-29 1992-12-08 Snyders Robert V Ventricular assist device
US5188619A (en) * 1991-04-24 1993-02-23 Gene E. Myers Enterprises, Inc. Internal thoractic artery catheter
US5192314A (en) * 1991-12-12 1993-03-09 Daskalakis Michael K Synthetic intraventricular implants and method of inserting
US5197979A (en) * 1990-09-07 1993-03-30 Baxter International Inc. Stentless heart valve and holder
US5203776A (en) * 1992-10-09 1993-04-20 Durfee Paul J Catheter
US5250038A (en) * 1992-10-09 1993-10-05 Cook Incorporated Multiple lumen vascular access introducer sheath
US5250049A (en) * 1992-01-10 1993-10-05 Michael Roger H Bone and tissue connectors
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5308320A (en) * 1990-12-28 1994-05-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method
US5312344A (en) * 1991-02-25 1994-05-17 Grinfeld Roberto R Arterial perfusion cannula for extracorporeal circulation and other uses
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5339800A (en) * 1992-09-10 1994-08-23 Devmed Group Inc. Lens cleaning means for invasive viewing medical instruments with anti-contamination means
US5385528A (en) * 1993-06-17 1995-01-31 Wilk; Peter J. Intrapericardial assist device and associated method
US5391156A (en) * 1992-06-30 1995-02-21 Ethicon, Inc. Flexible encoscopic surgical port
WO1995015715A1 (en) * 1993-12-06 1995-06-15 Heartport, Inc. Devices and methods for intracardiac procedures
US5433727A (en) * 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
US5433700A (en) * 1992-12-03 1995-07-18 Stanford Surgical Technologies, Inc. Method for intraluminally inducing cardioplegic arrest and catheter for use therein
US5450860A (en) * 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
US5452733A (en) * 1993-02-22 1995-09-26 Stanford Surgical Technologies, Inc. Methods for performing thoracoscopic coronary artery bypass
US5458574A (en) * 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
US5496305A (en) * 1985-03-22 1996-03-05 Massachusetts Institue Of Technology Catheter for laser angiosurgery
US5501698A (en) * 1994-02-14 1996-03-26 Heartport, Inc. Endoscopic microsurgical instruments and methods
US5509428A (en) * 1994-05-31 1996-04-23 Dunlop; Richard W. Method and apparatus for the creation of tricuspid regurgitation
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5584803A (en) * 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5593424A (en) * 1994-08-10 1997-01-14 Segmed, Inc. Apparatus and method for reducing and stabilizing the circumference of a vascular structure
US5603337A (en) * 1994-12-05 1997-02-18 Jarvik; Robert Two-stage cardiomyoplasty
US5613302A (en) * 1995-08-22 1997-03-25 Berman; Paul Circumferential waist measuring device
US5665092A (en) * 1993-03-01 1997-09-09 Mangiardi; John R. Marker for surgical procedures
US5682906A (en) * 1993-02-22 1997-11-04 Heartport, Inc. Methods of performing intracardiac procedures on an arrested heart
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US5718725A (en) * 1992-12-03 1998-02-17 Heartport, Inc. Devices and methods for intracardiac procedures
US5738626A (en) * 1996-06-14 1998-04-14 Jarvik; Robert Two-step cardiomyoplasty with ventricular reduction
US5758663A (en) * 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5800334A (en) * 1993-06-17 1998-09-01 Wilk; Peter J. Intrapericardial assist device and associated method
US5800528A (en) * 1995-06-13 1998-09-01 Abiomed R & D, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US5810721A (en) * 1996-03-04 1998-09-22 Heartport, Inc. Soft tissue retractor and method for providing surgical access
US5814097A (en) * 1992-12-03 1998-09-29 Heartport, Inc. Devices and methods for intracardiac procedures
US5814098A (en) * 1995-06-07 1998-09-29 St. Jude Medical, Inc. Adjustable sizing apparatus
US5849005A (en) * 1995-06-07 1998-12-15 Heartport, Inc. Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity
US5856614A (en) * 1996-04-08 1999-01-05 Dekalb Genetics Corporation Inbred corn plants 01IZB2 and seeds thereof
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5957977A (en) * 1996-01-02 1999-09-28 University Of Cincinnati Activation device for the natural heart including internal and external support structures
US5971911A (en) * 1993-06-17 1999-10-26 Wilk; Peter J. Intrapericardial assist device and associated method
US5972030A (en) * 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
US5984857A (en) * 1991-09-30 1999-11-16 Thoratec Laboratories Corporation Step-down skeletal muscle energy conversion system
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
US6079474A (en) * 1999-08-06 2000-06-27 Lin; Yung-Ching Sun-shade assembly
US6125852A (en) * 1993-02-22 2000-10-03 Heartport, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US6182664B1 (en) * 1996-02-19 2001-02-06 Edwards Lifesciences Corporation Minimally invasive cardiac valve surgery procedure
US6217610B1 (en) * 1994-07-29 2001-04-17 Edwards Lifesciences Corporation Expandable annuloplasty ring
US6258021B1 (en) * 1993-06-17 2001-07-10 Peter J. Wilk Intrapericardial assist method
US6283993B1 (en) * 1989-07-31 2001-09-04 Edwards Lifesciences Corporation Annuloplasty ring delivery system
US20020007216A1 (en) * 1996-01-02 2002-01-17 Melvin David Boyd Heart wall actuation device for the natural heart
US20020029783A1 (en) * 1993-02-22 2002-03-14 Stevens John H. Minimally-invasive devices and methods for treatment of congestive heart failure
US20020111533A1 (en) * 1996-01-02 2002-08-15 Melvin David Boyd Device and method for restructuring heart chamber geometry
US20030045896A1 (en) * 2001-02-28 2003-03-06 Chase Medical, Lp Method of using a ventricular restoration shaping apparatus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8502382A (en) 1985-08-30 1987-03-16 Martinus Jacobus Antonius Joha CATHETER SUITABLE FOR MULTIPLE PURPOSES.
DE3614292C1 (en) 1986-04-26 1987-11-19 Alexander Prof Dr Bernhard Holder for unframed biological mitral valve implant
US4925443A (en) 1987-02-27 1990-05-15 Heilman Marlin S Biocompatible ventricular assist and arrhythmia control device
US5225162A (en) * 1990-10-17 1993-07-06 Sps Medical Supply Corporation Disposable tamper evident locking device
WO1993020741A1 (en) 1992-04-08 1993-10-28 Jako Geza J Percutaneous surgical endoscopy
US5396880A (en) 1992-04-08 1995-03-14 Danek Medical, Inc. Endoscope for direct visualization of the spine and epidural space
DE4234127C2 (en) 1992-10-09 1996-02-22 Herbert Dr Vetter Heart valve prosthesis
US5797960A (en) 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5562687A (en) * 1993-07-12 1996-10-08 Mitek Surgical Products, Inc. Surgical repair kit and its method of use
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
WO1997024083A1 (en) 1993-11-01 1997-07-10 Cox James L Method of replacing heart valves using flexible tubes
CA2181045C (en) 1993-12-17 2004-08-31 John H. Stevens System for cardiac procedures

Patent Citations (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409013A (en) * 1965-08-23 1968-11-05 Berry Henry Instrument for inserting artificial heart valves
US3779234A (en) * 1971-06-30 1973-12-18 Intersc Res Inst Ultrasonic catheter with rotating transducers
US3827115A (en) * 1972-02-22 1974-08-06 Univ Erasmus Method of manufacturing a catheter
US3938502A (en) * 1972-02-22 1976-02-17 Nicolaas Bom Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves
US4042979A (en) * 1976-07-12 1977-08-23 Angell William W Valvuloplasty ring and prosthetic method
US4173981A (en) * 1977-05-23 1979-11-13 University Of Utah Cannula for arterial and venous bypass cannulation
US4192293A (en) * 1978-09-05 1980-03-11 Manfred Asrican Cardiac assist device
US4261342A (en) * 1978-10-26 1981-04-14 Iker Aranguren Duo Process for installing mitral valves in their anatomical space by attaching cords to an artificial stent
US4349033A (en) * 1980-11-06 1982-09-14 Eden Robert D Intrauterine catheter
US4372293A (en) * 1980-12-24 1983-02-08 Vijil Rosales Cesar A Apparatus and method for surgical correction of ptotic breasts
US4409974A (en) * 1981-06-29 1983-10-18 Freedland Jeffrey A Bone-fixating surgical implant device
US4536893A (en) * 1982-03-03 1985-08-27 Roberto Parravicini Implant device for substaining the activity of the myocardium
US4624671A (en) * 1984-06-25 1986-11-25 Kress Donald W Method of sizing and implanting breast prosthesis
US5496305A (en) * 1985-03-22 1996-03-05 Massachusetts Institue Of Technology Catheter for laser angiosurgery
US4690134A (en) * 1985-07-01 1987-09-01 Snyders Robert V Ventricular assist device
US4655218A (en) * 1985-10-23 1987-04-07 Blagoveschensky Gosudarstuvenny Meditsinsky Institut Prosthetic valve holder
US4705040A (en) * 1985-11-18 1987-11-10 Medi-Tech, Incorporated Percutaneous fixation of hollow organs
USRE34021E (en) * 1985-11-18 1992-08-04 Abbott Laboratories Percutaneous fixation of hollow organs
US4936857A (en) * 1987-02-23 1990-06-26 Kulik Yaroslav P Prosthetic pericardium
US4808163A (en) * 1987-07-29 1989-02-28 Laub Glenn W Percutaneous venous cannula for cardiopulmonary bypass
US4960424A (en) * 1988-06-30 1990-10-02 Grooters Ronald K Method of replacing a defective atrio-ventricular valve with a total atrio-ventricular valve bioprosthesis
US5032128A (en) * 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US5011469A (en) * 1988-08-29 1991-04-30 Shiley, Inc. Peripheral cardiopulmonary bypass and coronary reperfusion system
US4944753A (en) * 1988-09-26 1990-07-31 Burgess Frank M Method for producing retro-sternal space
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5104407B1 (en) * 1989-02-13 1999-09-21 Baxter Int Selectively flexible annuloplasty ring
US5041130A (en) * 1989-07-31 1991-08-20 Baxter International Inc. Flexible annuloplasty ring and holder
US6283993B1 (en) * 1989-07-31 2001-09-04 Edwards Lifesciences Corporation Annuloplasty ring delivery system
US5104393A (en) * 1989-08-30 1992-04-14 Angelase, Inc. Catheter
US5106386A (en) * 1989-08-30 1992-04-21 Angelase, Inc. Catheter
US4997431A (en) * 1989-08-30 1991-03-05 Angeion Corporation Catheter
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
US5197979A (en) * 1990-09-07 1993-03-30 Baxter International Inc. Stentless heart valve and holder
US5308320A (en) * 1990-12-28 1994-05-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method
US5312344A (en) * 1991-02-25 1994-05-17 Grinfeld Roberto R Arterial perfusion cannula for extracorporeal circulation and other uses
US5169381A (en) * 1991-03-29 1992-12-08 Snyders Robert V Ventricular assist device
US5188619A (en) * 1991-04-24 1993-02-23 Gene E. Myers Enterprises, Inc. Internal thoractic artery catheter
US5584803A (en) * 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5984857A (en) * 1991-09-30 1999-11-16 Thoratec Laboratories Corporation Step-down skeletal muscle energy conversion system
US5192314A (en) * 1991-12-12 1993-03-09 Daskalakis Michael K Synthetic intraventricular implants and method of inserting
US5250049A (en) * 1992-01-10 1993-10-05 Michael Roger H Bone and tissue connectors
US5758663A (en) * 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5391156A (en) * 1992-06-30 1995-02-21 Ethicon, Inc. Flexible encoscopic surgical port
US5339800A (en) * 1992-09-10 1994-08-23 Devmed Group Inc. Lens cleaning means for invasive viewing medical instruments with anti-contamination means
US5203776A (en) * 1992-10-09 1993-04-20 Durfee Paul J Catheter
US5250038A (en) * 1992-10-09 1993-10-05 Cook Incorporated Multiple lumen vascular access introducer sheath
US5718725A (en) * 1992-12-03 1998-02-17 Heartport, Inc. Devices and methods for intracardiac procedures
US5814097A (en) * 1992-12-03 1998-09-29 Heartport, Inc. Devices and methods for intracardiac procedures
US5433700A (en) * 1992-12-03 1995-07-18 Stanford Surgical Technologies, Inc. Method for intraluminally inducing cardioplegic arrest and catheter for use therein
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US20020029783A1 (en) * 1993-02-22 2002-03-14 Stevens John H. Minimally-invasive devices and methods for treatment of congestive heart failure
US5571215A (en) * 1993-02-22 1996-11-05 Heartport, Inc. Devices and methods for intracardiac procedures
US5972030A (en) * 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
US6125852A (en) * 1993-02-22 2000-10-03 Heartport, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US5682906A (en) * 1993-02-22 1997-11-04 Heartport, Inc. Methods of performing intracardiac procedures on an arrested heart
US5452733A (en) * 1993-02-22 1995-09-26 Stanford Surgical Technologies, Inc. Methods for performing thoracoscopic coronary artery bypass
US5665092A (en) * 1993-03-01 1997-09-09 Mangiardi; John R. Marker for surgical procedures
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5971911A (en) * 1993-06-17 1999-10-26 Wilk; Peter J. Intrapericardial assist device and associated method
US6258021B1 (en) * 1993-06-17 2001-07-10 Peter J. Wilk Intrapericardial assist method
US5800334A (en) * 1993-06-17 1998-09-01 Wilk; Peter J. Intrapericardial assist device and associated method
US5385528A (en) * 1993-06-17 1995-01-31 Wilk; Peter J. Intrapericardial assist device and associated method
US5450860A (en) * 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
WO1995015715A1 (en) * 1993-12-06 1995-06-15 Heartport, Inc. Devices and methods for intracardiac procedures
US5501698A (en) * 1994-02-14 1996-03-26 Heartport, Inc. Endoscopic microsurgical instruments and methods
US5458574A (en) * 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
US5509428A (en) * 1994-05-31 1996-04-23 Dunlop; Richard W. Method and apparatus for the creation of tricuspid regurgitation
US6217610B1 (en) * 1994-07-29 2001-04-17 Edwards Lifesciences Corporation Expandable annuloplasty ring
US5593424A (en) * 1994-08-10 1997-01-14 Segmed, Inc. Apparatus and method for reducing and stabilizing the circumference of a vascular structure
US5433727A (en) * 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
US5603337A (en) * 1994-12-05 1997-02-18 Jarvik; Robert Two-stage cardiomyoplasty
US5814098A (en) * 1995-06-07 1998-09-29 St. Jude Medical, Inc. Adjustable sizing apparatus
US5849005A (en) * 1995-06-07 1998-12-15 Heartport, Inc. Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US6224540B1 (en) * 1995-06-13 2001-05-01 Abiomed, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US5800528A (en) * 1995-06-13 1998-09-01 Abiomed R & D, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US5613302A (en) * 1995-08-22 1997-03-25 Berman; Paul Circumferential waist measuring device
US5957977A (en) * 1996-01-02 1999-09-28 University Of Cincinnati Activation device for the natural heart including internal and external support structures
US20020007216A1 (en) * 1996-01-02 2002-01-17 Melvin David Boyd Heart wall actuation device for the natural heart
US20020022880A1 (en) * 1996-01-02 2002-02-21 Melvin David B. Device and method for restructuring heart chamber geometry
US20020111533A1 (en) * 1996-01-02 2002-08-15 Melvin David Boyd Device and method for restructuring heart chamber geometry
US6221103B1 (en) * 1996-01-02 2001-04-24 The University Of Cincinnati Device and method for restructuring heart chamber geometry
US6182664B1 (en) * 1996-02-19 2001-02-06 Edwards Lifesciences Corporation Minimally invasive cardiac valve surgery procedure
US20010003986A1 (en) * 1996-02-19 2001-06-21 Cosgrove Delos M. Minimally invasive cardiac surgery procedure
US5810721A (en) * 1996-03-04 1998-09-22 Heartport, Inc. Soft tissue retractor and method for providing surgical access
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
US6117159A (en) * 1996-03-22 2000-09-12 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
US5856614A (en) * 1996-04-08 1999-01-05 Dekalb Genetics Corporation Inbred corn plants 01IZB2 and seeds thereof
US5738626A (en) * 1996-06-14 1998-04-14 Jarvik; Robert Two-step cardiomyoplasty with ventricular reduction
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6079474A (en) * 1999-08-06 2000-06-27 Lin; Yung-Ching Sun-shade assembly
US20030045896A1 (en) * 2001-02-28 2003-03-06 Chase Medical, Lp Method of using a ventricular restoration shaping apparatus

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Eaton et al. "Accurate volume determination in the isolated ejecting canine left ventricle by two-dimensional echocardiography." Circulation 60 (1979): 320-326. *
Gaynor et al. "Measurement of left ventricular volume in normal and volume-overloaded canine hearts". Am J Physiol Heart Circ Physiol 266 (1994): H329-H340. *
Goto et al. "Accuracy of volume measurement of rabbit left ventricle by balloon method". Am J Physiol Heart Circ Physiol 255 (1988): H394-H396. *
Suga et al. "Accuracy of ventricular lumen volume measurement by intraventricular balloon method." Am J Physiol Heart Circ Physiol 236(1979): H506-H507. *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900294B2 (en) 2002-01-04 2014-12-02 Colibri Heart Valve Llc Method of controlled release of a percutaneous replacement heart valve
US8109995B2 (en) 2002-01-04 2012-02-07 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US8790398B2 (en) 2002-01-04 2014-07-29 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9610158B2 (en) 2002-01-04 2017-04-04 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9125739B2 (en) 2002-01-04 2015-09-08 Colibri Heart Valve Llc Percutaneous replacement heart valve and a delivery and implantation system
US9554898B2 (en) 2002-01-04 2017-01-31 Colibri Heart Valve Llc Percutaneous prosthetic heart valve
US9186248B2 (en) 2002-01-04 2015-11-17 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US20110024614A1 (en) * 2006-10-19 2011-02-03 Syft Technologies Limited Sift-ms instrument
US9440054B2 (en) 2008-05-14 2016-09-13 Onset Medical Corporation Expandable transapical sheath and method of use
US20090287183A1 (en) * 2008-05-14 2009-11-19 Onset Medical Corporation Expandable transapical sheath and method of use
US8728153B2 (en) 2008-05-14 2014-05-20 Onset Medical Corporation Expandable transapical sheath and method of use
US20110144690A1 (en) * 2008-05-14 2011-06-16 Onset Medical Corporation Expandable transapical sheath and method of use
US8361144B2 (en) 2010-03-01 2013-01-29 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US10973632B2 (en) 2010-12-14 2021-04-13 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US20150089428A1 (en) * 2013-09-24 2015-03-26 Microsoft Corporation Quick Tasks for On-Screen Keyboards
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks

Also Published As

Publication number Publication date
US7213601B2 (en) 2007-05-08
US20040055608A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
US6125852A (en) Minimally-invasive devices and methods for treatment of congestive heart failure
US7213601B2 (en) Minimally-invasive devices and methods for treatment of congestive heart failure
US20020029783A1 (en) Minimally-invasive devices and methods for treatment of congestive heart failure
US11058536B2 (en) Method for replacement of heart valve
US6010531A (en) Less-invasive devices and methods for cardiac valve surgery
US6182664B1 (en) Minimally invasive cardiac valve surgery procedure
JP3717929B2 (en) Prosthetic assembly for non-thoracotomy replacement of heart valves
EP2378947B1 (en) Device for endoscopic access to the heart
US5613937A (en) Method of retracting heart tissue in closed-chest heart surgery using endo-scopic retraction
US6899704B2 (en) Devices and methods for intracardiac procedures
US20230233228A1 (en) Devices and methods for accessing the left atrium for cardiac procedures
US20210321996A1 (en) Devices and methods for catheter-based cardiac procedures

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION